최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.17 no.8 = no.88, 2007년, pp.1027 - 1033
장정현 (부산카톨릭대학교 보건과학대학 임상병리학과) , 김광연 (부산대학교 미생물학 및 면역학교실) , 안순철 (부산대학교 미생물학 및 면역학교실) , 권헌영 (부산카톨릭대학교 보건과학대학 임상병리학과)
Although paclitaxel induces apoptosis of cancer cells, its exact mechanism of action is not yet known. The present study has been performed to determine whether influence of paclitaxel in HeLa
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Amos, L. A. and J. Lowe. 1999. Tubulin-like protofilaments in ca-induced FtsZ sheets. Chem. Biol. 6, 65-69.
Bava, S. V., T. V. Puliappadamba, A. Deepti, A. Nair, D. Karunagaran and R. J. Anto. 2005. Sensitization of Taxol-induced Apoptosis by Curcumin Involves Downregulation of Nuclear Factor-B and the Serine/Threonine Kinase Akt and Is Independent of Tubulin Polymerization. J. Bio. Chem. 280, 6301-6308.
Benford, H. L., N. W. A. McGowan, M. H. Helfrich, M. E. Nuttall and M. J. Rogers. 2001. Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone. 28, 465-473.
Cain, K., D. G. Brown, C. Langlais and G. M. Cohen. 1999. Caspase activation involves the formation of the aposome, a large (approximately 700 kDa) caspase-activating complex. J. Biol. Chem. 274, 22686-22692.
Crown, J. and M. O'Leary. 2000. The taxanes: an update. Lancet 355, 1176-1178.
Earnshaw, W. C. 1995. Nuclear Changes in Apoptosis. Curr. Opin. Cell Biol. 7, 337-343.
Fadok, V. A., D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton and P. M. Henson. 1992. Exposure of ph osphatidylserine on the surface of apoptotic lymphocytes biggers specific recognition and removal by macrophages. J. Immunol. 148, 2207.
Fink, S. L. and B. T. Cookson. 2005. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73, 1907-1916.
Fischer, U., R. U. Jaicke and Schulze-Osthoff, K. 2003. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 10, 76-100.
Gavrieli, Y, Y. Sherman and S. A. Ben-Sasson, 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119(3), 493-501.
Green, D. R. 2000. Apoptotic PathwaysPaper Wraps Stone Blunts Scissors. Cell 102, 1-4.
Holstein, A. S. and J. H Raymond. 2001. Synergistic Interaction of Lovastatin and Paclitaxel in Human Cancer Cells. Mol. Cancer Thera. 1, 141-149.
Homburg, C. H, M. de Haas, A. E. von dem Borne, A. J. Verhoeven, C. P. Reutelingsperger and D. Roos. 1995. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood. 85, 532-540.
Hu, Y., M. A. Benedict, L. Ding and G. Nunez. 1999. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis, EMBO J. 18, 3586-3595.
Huisman, C., C. G. Ferreira, L. E. Broker, J. A. Rodriguez, E. F. Smit, P. E. Postmus, F. A. Kruyt and G. Giaccone. 2002. Paclitaxel triggers cell death primarily via. caspase-independent routes in the non-small cell lung cancer cell line NCI-. H460. Clin. Cancer Res. 8, 596-606.
Howitz, S. B. 1999. Mechanism of action of taxol. Trends Phamacol. Sci. 13, 134-136.
Jaattela, M. and M. Tschopp. 2003. Caspase-independent cell death in T lymphocytes. Nat. Immunol. 4, 416-423.
Jiang, X. and X. Wang, 2004. Cytochrome C-mediated apoptosis. Annu. Rev. Biochem. 73, 87-106.
Kim, R. 2005. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 103, 1551-1560.
Kohn, E. C., G Sarosy, A. Bicher, C. Link, M. Christian, S. M. Steinberg, M. Rothenberg, D. O. Adamo, P. Davis and F. P. Ognibene. 1994. Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer. J. Natl. Cancer Inst. 86, 18-24.
Kumar, S. and M. F. Lavin. 1996. The ICE family of cysteine proteases as effectors of cell death. Cell Death Differ. 3, 255-267.
Koopman, G., C. P. Reutelingsperger, G. A. M. Kuijten, R. M. J. Keehnen, S. T. Pals and M. H. J. van Oers, 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84, 1415-1421.
Krauss, T., A. Huschmand Nia, V. Viereck and G. Emons. 2001. New developments in the treatment of cervical cancer. Onkologie 243, 40-45.
Le, N. T. and D. R. Richardson. 2002. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim. Biophys. Acta. 1603, 31-46.
Leung, M. F., J. A. Sokoloski and A. C. Sartorelli. 1992. Changes in microtubules, microtubule-associated proteins, and intermediate filaments during the differentiation of HL-60 leukemia cells. Cancer Res. 52, 949-954.
Li. P. D., I. Nijhawan, I. Budihardjo, S. M. Srinivasula, M. Ahmad, E. S. Alnemri and X. Wang. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
Mullan, P. B., J. E. Quinn, P. M. Gilmore, S. McWilliams, H. Andrews, C. Gervin, N. McCabe, S. McKenna, P. White, Y. H. Song, S. Maheswaran, E. Liu, D. A. Haber, P. G. Johnston and D. P. Harkin. 2001. BRCA1 regulates the interferon gamma mediated apoptotic response. Oncogene 20, 6123-6131.
Nicholson, D. W. 1992. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6, 1028-1042.
Ofir, R., R. Seidman, T. Rabinski, M. Krup, V. Yavelsky, Y. Weinstein and M. Wolfson. 2002. Taxol-induced apoptosis in human SKOV3 ovarian and MCF7 breast carcinoma cells is caspase-3 and caspase-9 independent. Cell Death Differ. 9, 636-642.
Okahashi, N., M. Koide, E. Jimi, T. Suda and T. Nishihara. 1998. Caspases (interleukin-1beta-converting enzyme family proteases) are involved in the regulation of the survival of osteoclasts. Bone 23, 33-41.
Peter, M. E. and P. H. Krammer. 2003. The CD95 (APO-1/Fas) DISC and beyond. Cell Death Differ. 10, 26-35.
Park, S. J., C. H. Wu and D. John. 2004. Gordon Xiaoling Zhong, Armaghan Emami and Ahmad R. Safa. Taxol Induces Caspase-10-dependent Apoptosis. J. Bio. Chem. 279, 51057-51067.
Salvesen, G. S. and V. M. Dixit. 1994. Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA. 96, 10964-10967.
Schulze-Osthoff, K., D. Ferrari, M. Los, S. Wesselborg and M. E. Peter. 1998. Apoptosis signaling by death receptors. Eur. J. Biochem. 254, 439-459.
Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. 1995. Science 267, 1456-1462.
Yoo, Y. D., J. K. Park, J. Y. Choi, K. H. Lee, Y. K. Kang, C. S. Kim, S. W. Shin, Y. H. Kim and J. S. Kim. 1999. CDK4 down-regulation induced by paclitaxel is associated with G1 arrest in gastric cancer cells. Clin. Cancer Res. 4, 3063-3068.
Vermes, I., C. Haanen, H. Steffens-Nakken and C. Reutelingsperger 1995. Reutelingsperger ANNEXIN V J. Immunol. Meth. 184, 39.
Vikhanskaya, F., S. Vignati, P. Beccaglia, C. Ottoboni, P. Russo, M. D'Incalci and M. Broggini. 1998. Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis, Exp. Cell Res. 241, 96-101.
Vorobiof, D. A., B. L. Rapoport, M. R. Chasen, C. Slabber, G. McMichael, R. Eek and C. Mohammed. 2004. First line therapy with paclitaxel (Taxol) and pegylated liposomal doxorubicin (Caelyx) in patients with metastatic breast cancer: a multicentre phase II study. Breast 13, 219-226.
Wood, B. L, D. F. Gibson and J. F. Tait. 1996. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood. 88, 1873-1880.
Wieder, T., F. Essmann, A. Prokop, K. Schmelz, K. Schulze-Osthoff, R. Beyaert, B. Dorken and P. T. Daniel 2001. Activation of caspase-8 in drug-induced apoptosis of B-lyrnphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Blood. 97, 1378-1387.
Zanetta, G., F. Fei and C. Mangioni. 2000. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of monza, Semin. Oncol. 27, 23-27.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.